Tibet Rhodiola Pharmaceutical Holding Co.

SHSE:600211 Voorraadrapport

Marktkapitalisatie: CN¥12.6b

Tibet Rhodiola Pharmaceutical Holding Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yuan Dong Guo

Algemeen directeur

CN¥3.4m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO7.5yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn7.5yrs
Gemiddelde ambtstermijn bestuur7.5yrs

Recente managementupdates

Recent updates

At CN¥33.30, Is Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Worth Looking At Closely?

Sep 25
At CN¥33.30, Is Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Worth Looking At Closely?

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt

Sep 02
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt

Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price

Jul 29
Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price

Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital

Jul 12
Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly

May 21
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly

Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings

May 03
Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings

Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive

Mar 22
Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive

CEO

Yuan Dong Guo (52 yo)

7.5yrs

Tenure

CN¥3,437,900

Compensatie

Mr. Yuan Dong Guo serves as General Manager and Director of Tibet Rhodiola Pharmaceutical Holding Company since May 8, 2017. Mr. Guo served as the Chairman of the Board of Directors and Deputy General Mana...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yuan Dong Guo
GM & Director7.5yrsCN¥3.44mgeen gegevens
Jun Chen
Financial Director5.1yrsCN¥736.70kgeen gegevens
Lan Liu
Deputy GM & Secretary of the Board7.5yrsCN¥1.07mgeen gegevens

7.5yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 600211 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yuan Dong Guo
GM & Director7.5yrsCN¥3.44mgeen gegevens
Dabin Chen
Chairman of the Board7.5yrsCN¥3.44mgeen gegevens
Yu Cheng Zhou
Vice Chairman of the Board7.5yrsCN¥1.81mgeen gegevens
Pei Yao
Chairman of the Supervisory Board7.5yrsgeen gegevensgeen gegevens
Sanyan Wu
Director4.5yrsCN¥80.00kgeen gegevens
Ma Lie Yi
Director7.5yrsCN¥80.00kgeen gegevens
Tiantian Tang
Supervisor5.6yrsgeen gegevensgeen gegevens
Yu Zhang
Independent Director2.9yrsCN¥180.00kgeen gegevens

7.5yrs

Gemiddelde duur

49.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 600211 wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.5 jaar).